DrugPatentWatch Database Preview
Profile for Serbia Patent: 50214
US Patent Family Members and Approved Drugs for Serbia Patent: 50214
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Feb 24, 2022 | Allergan Sales Llc | AVYCAZ | avibactam sodium; ceftazidime |
➤ Try a Free Trial | Jul 24, 2021 | Allergan Sales Llc | AVYCAZ | avibactam sodium; ceftazidime |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |